Monomethylation at the K224 residue of PGCla (PGCla K224me), which was elevated in GBM stem cells, was regulated by SMYD2, as high SMYD2 expression led to high PGCla K224me levels. The gene discussed is SMYD2; the disease is glioblastoma.